<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/091A7281-194A-4C7B-8E9A-0CEB4FEE954B"><gtr:id>091A7281-194A-4C7B-8E9A-0CEB4FEE954B</gtr:id><gtr:name>Faculty of Medicine</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:department>Oxford Chemistry</gtr:department><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/091A7281-194A-4C7B-8E9A-0CEB4FEE954B"><gtr:id>091A7281-194A-4C7B-8E9A-0CEB4FEE954B</gtr:id><gtr:name>Faculty of Medicine</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/97EADE10-8A46-476A-B920-E82391CC95EC"><gtr:id>97EADE10-8A46-476A-B920-E82391CC95EC</gtr:id><gtr:firstName>Dermot</gtr:firstName><gtr:surname>O'Hare</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0802620"><gtr:id>D2D08267-5602-4787-8418-043572C7DFA7</gtr:id><gtr:title>'Designer' Inorganic Vaccine Adjuvants</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0802620</gtr:grantReference><gtr:abstractText>Effective vaccines need to contain both an antigen, e.g. a viral, microbial or tumour component, and crucially an adjuvant. The role of a vaccine adjuvant is to reproduce or mimic the ?danger signals? that naturally trigger immune responses and so enhance the efficiently of the vaccine. Very few vaccine adjuvants are currently licensed for human use, they are poorly understood mixtures of aluminium and magnesium salts, and it appears that even the most basic understanding of the chemistry of these materials is almost totally lacking. This research grant application proposes to study carefully prepared pure inorganic compounds with well defined composition, size and shape so that we can begin to unravel the chemical and structure factors that affect the efficient of vaccine adjuvants. If successful, this project will offer the exciting possibility of creating the next generation of effective, safe and cheap inorganic adjuvants for global use in vaccination.</gtr:abstractText><gtr:technicalSummary>The purpose of this Discipline Hopping application is to support research that plans to take synthetic Inorganic Chemistry into Immunology. Inorganic aluminium compounds such as alum(s) are currently used to enhance immunity induced by vaccines. Remarkably, it appears that even the most basic understanding of the inorganic chemistry of the alum(s) used as vaccine adjuvants is almost totally lacking. We propose to prepare a series of tailor-made metal hydroxides known as Layered Double Hydroxides (LDHs) with specific chemical composition, crystal size and morphology that are designed to unravel the physico-chemical factors that control the vaccine adjuvanticity of inorganic metal hydroxides. Through the collaboration with the Department of Surgery we propose to learn how to evaluate the immunological properties of these LDHs. We propose to develop a relatively simple but informative assay in order to identify lead compounds that can subsequently be assessed for their adjuvant properties in vivo. For example, an important function of adjuvants is to induce the secretion of pro-inflammatory cytokines such as IL-1 by cells such as dendritic cells and macrophages. We proposed to learn both culture techniques for growing these cell types and the analytics for detecting the key signalling molecules.</gtr:technicalSummary><gtr:fund><gtr:end>2010-09-20</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2009-09-21</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>99944</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London (UCL)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>UCL Centre for Clinical Pharmacology &amp; Therapeutics</gtr:department><gtr:description>Oxford-Ghent advanced adjuvants initiative</gtr:description><gtr:id>852D318B-B887-486F-BA97-92C4D13BAD5E</gtr:id><gtr:impact>A patent application was filed in May 10. A publication based on the research is being prepared for submission to Science.</gtr:impact><gtr:partnerContribution>Undertaking in vitro experiments adjuvancy with human DC cells</gtr:partnerContribution><gtr:piContribution>Synthesis and characterisation of novel inorganic adjuvants. Study of their effect on human cells in in vitro experiments. Microarray experiment. Programme planning and advice on experimental design.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Faculty of Medicine</gtr:collaboratingOrganisation><gtr:country>Belgium, Kingdom of</gtr:country><gtr:department>Department of Internal Medicine</gtr:department><gtr:description>Oxford-Ghent advanced adjuvants initiative</gtr:description><gtr:id>512D3B2A-2183-4878-9D85-B892569F74C0</gtr:id><gtr:impact>A patent application was filed in May 10. A publication based on the research is being prepared for submission to Science.</gtr:impact><gtr:partnerContribution>Undertaking in vitro experiments adjuvancy with human DC cells</gtr:partnerContribution><gtr:piContribution>Synthesis and characterisation of novel inorganic adjuvants. Study of their effect on human cells in in vitro experiments. Microarray experiment. Programme planning and advice on experimental design.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>A range of inorganic materials were found to act as adjuvants. Some were more potent that alum (the current industry standard), whereas others provoked different types of immune response.
Application from Isis Innovation Limited and Universiteit Gent</gtr:description><gtr:id>CBF08608-5C9C-417B-B4E4-4A1B567D05B2</gtr:id><gtr:impact>Some compounds allowed Th1 responses to be provoked in vivo, which could be beneficial for treatment of/immunization to cancer or viral infections.</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:patentId>GB1005931.9</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>Novel inorganic adjuvants</gtr:title><gtr:yearProtectionGranted>2011</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>As a result of a systematic investigation into the effects of adjuvants on human and mouse cells, we now have a panel of assays that can be used to suggest which materials may be effective as adjuvants in vivo from in vitro data.</gtr:description><gtr:id>87919343-07D0-45FD-BFA9-4A9B4FE73015</gtr:id><gtr:impact>None as yet, but may enable animal usage to be decreased in the future.</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>In vitro assays for adjuvant efficacy</gtr:title><gtr:type>Physiological assessment or outcome measure</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3F008CCA-CA46-4EB7-9421-63DA3161E6D5"><gtr:id>3F008CCA-CA46-4EB7-9421-63DA3161E6D5</gtr:id><gtr:title>Cellular uptake and gene delivery using layered double hydroxide nanoparticles</gtr:title><gtr:parentPublicationTitle>J. Mater. Chem. B</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b8a46f3752fd4026773cf1b531707cbf"><gtr:id>b8a46f3752fd4026773cf1b531707cbf</gtr:id><gtr:otherNames>Li S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/05A9AE10-AC8D-41CF-8CE7-0684E362B3D0"><gtr:id>05A9AE10-AC8D-41CF-8CE7-0684E362B3D0</gtr:id><gtr:title>Bile canalicular dynamics in hepatocyte sandwich cultures.</gtr:title><gtr:parentPublicationTitle>Archives of toxicology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/eed35c4bf1b2535fb903527ae1158e77"><gtr:id>eed35c4bf1b2535fb903527ae1158e77</gtr:id><gtr:otherNames>Reif R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0340-5761</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F6E817C0-EF19-4B80-A5FF-37A03D1A158A"><gtr:id>F6E817C0-EF19-4B80-A5FF-37A03D1A158A</gtr:id><gtr:title>Immunity induced by a broad class of inorganic crystalline materials is directly controlled by their chemistry.</gtr:title><gtr:parentPublicationTitle>The Journal of experimental medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/7da87018868ec7d6ea563e1daaef4ac8"><gtr:id>7da87018868ec7d6ea563e1daaef4ac8</gtr:id><gtr:otherNames>Williams GR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-1007</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/CF098C2C-A311-4F91-84C5-10EA960150C9"><gtr:id>CF098C2C-A311-4F91-84C5-10EA960150C9</gtr:id><gtr:title>Bone marrow-derived and resident liver macrophages display unique transcriptomic signatures but similar biological functions.</gtr:title><gtr:parentPublicationTitle>Journal of hepatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3f74cb360370ab50a1ef10a822c94104"><gtr:id>3f74cb360370ab50a1ef10a822c94104</gtr:id><gtr:otherNames>Beattie L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0168-8278</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/67B60464-B1B3-47CF-8D3A-6BD1CB42AF88"><gtr:id>67B60464-B1B3-47CF-8D3A-6BD1CB42AF88</gtr:id><gtr:title>Lessons from other diseases: granulomatous inflammation in leishmaniasis.</gtr:title><gtr:parentPublicationTitle>Seminars in immunopathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/7c89aed5fb181cf2634c915b0d4e12c9"><gtr:id>7c89aed5fb181cf2634c915b0d4e12c9</gtr:id><gtr:otherNames>Kaye PM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1863-2297</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0802620</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>C6D70A71-8796-47BC-AFE0-CC2286E66A06</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Inflammatory and Immune System</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>8EA3EC93-8E9C-482F-8121-C6C8413D9B6D</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.3  Chemical and physical sciences</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>